Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure

Masahiko Sumitani1, Kanji Uchida, Hideo Yasunaga

  • 1Department of Anesthesiology and Pain Relief Center, University of Tokyo Hospital, Tokyo, Japan. sumitanim-ane@h.u-tokyo.ac.jp

Anesthesiology
|December 21, 2010
PubMed
Abstract

Insights

Malignant hyperthermia (MH) is a rare anesthesia complication. This study found no specific anesthetic drug significantly linked to MH, though men were more susceptible. Further research is needed to identify causative agents.

Area of Science:

  • Anesthesiology
  • Pharmacovigilance
  • Medical Informatics

Background:

  • Malignant hyperthermia (MH) is a rare, life-threatening reaction during general anesthesia.
  • The true prevalence of MH and its association with anesthetic drugs are poorly understood due to inconsistent reporting.

Purpose of the Study:

  • To investigate the prevalence of MH and its association with anesthetic agents using a large national database.
  • To identify potential risk factors, including demographic factors and specific drugs, associated with MH occurrence.

Main Methods:

  • Analysis of inpatient data from the Japanese Diagnosis Procedure Combination database (2006-2008).
  • Inclusion of patients undergoing general anesthesia, examining age, gender, diagnoses, procedures, and anesthetic drug use (volatile agents, muscle relaxants, propofol).
  • Univariate comparisons to assess the relationship between anesthetic drugs/demographics and MH incidence.

Main Results:

  • Out of 1,238,171 patients, 17 cases of MH were identified; one in-hospital death occurred.
  • Men showed a significantly higher likelihood of developing MH (odds ratio: 3.49, P=0.029).
  • No MH cases were observed in 19,871 patients receiving suxamethonium; sevoflurane and rocuronium users showed a non-significant trend towards higher MH prevalence.

Conclusions:

  • No single anesthetic drug was found to be significantly associated with MH occurrence in this study.
  • Continuous data compilation and larger-scale analyses are essential to pinpoint potential causative agents for MH.
  • Further investigation is warranted to clarify the relationship between specific anesthetic agents and malignant hyperthermia.